Issue 31 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

36

No.

31

September 03, 2010Sep 03, 2010

DOWNLOAD THE PDF

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

Craig Thompson Of Abramson Center Named President, CEO, Of Memorial Sloan-Kettering

FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove

Committee To Set Research Agenda On Breast Cancer. Justice Department Appeals Injunction On Stem Cell Research

Recent Issues

Volume 52 | Issue 38 - October 16, 2026

Volume 52 | Issue 37 - October 09, 2026

Volume 52 | Issue 36 - October 02, 2026

Volume 52 | Issue 35 - September 25, 2026

Volume 52 | Issue 34 - September 18, 2026

Volume 52 | Issue 33 - September 11, 2026